NASDAQ | ETF
The fund invests at least 80% of its total assets in the securities of the underlying index.
The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, Genomics & Biotechnology Companies), as defined by Solactive AG, the provider of the underlying index.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 5.72% |
| VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | 5.00% |
| CRSP | Crispr Therapeutics AG | Healthcare | Biotechnology | 4.55% |
| QGEN | Qiagen NV | Healthcare | Diagnostics & Research | 4.30% |
| TECH | Bio-Techne Corp | Healthcare | Biotechnology | 4.26% |
| ARWR | Arrowhead Pharmaceuticals Inc | Healthcare | Biotechnology | 4.22% |
| A | Agilent Technologies Inc | Healthcare | Diagnostics & Research | 4.22% |
| BNTX | BioNTech SE | Healthcare | Biotechnology | 4.06% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 4.04% |
| RNA | Avidity Biosciences Inc | Healthcare | Biotechnology | 4.03% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 3.91% |
| LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 3.76% |
| BEAM | Beam Therapeutics Inc | Healthcare | Biotechnology | 3.62% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 3.56% |
| RARE | Ultragenyx | Healthcare | Biotechnology | 3.54% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 3.48% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 3.27% |
| 1548 | Genscript Biotech Corp | Healthcare | Biotechnology | 3.00% |
| NTLA | Intellia Therapeutics Inc | Healthcare | Biotechnology | 2.96% |
| MYGN | Myriad Genetics Inc | Healthcare | Diagnostics & Research | 2.78% |